NCT02959099 (ICONIC) is a clinical trial in Atherosclerosis, sponsored by Weill Medical College of Cornell University.

Who is sponsoring NCT02959099?

NCT02959099 is sponsored by Weill Medical College of Cornell University.

What condition does NCT02959099 study?

NCT02959099 studies Atherosclerosis.

Is NCT02959099 still recruiting?

NCT02959099 is currently completed. Last updated 19 November 2019.

Last reviewed 2019-11-19 · How we verify

NCT02959099: ICONIC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Incident COronary EveNts Identified by Computed Tomography

Completed Last updated 19 November 2019

What this trial tests

trial in Atherosclerosis in 476 participants. Completed in 30 April 2017.

Timeline

20 July 2012

Primary endpoint
30 April 2017

30 April 2017

Quick facts

Lead sponsor	Weill Medical College of Cornell University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	476
Start date	20 July 2012
Primary completion	30 April 2017
Estimated completion	30 April 2017
Sites	13 locations across Italy, Netherlands, Austria, Germany, South Korea, Canada, Portugal, United States

Conditions studied

Atherosclerosis — all drugs for Atherosclerosis →

Sponsor

Weill Medical College of Cornell University

Who can join

18 and older, any sex, with Atherosclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Incident COronary EveNts Identified by Coronary Tomography (ICONIC) trial is a nested, case-control study derived from the dynamic CONFIRM registry, and is based on propensity scoring methods to match subjects with (cases) or without (controls) acute coronary syndrome (ACS). Our primary objective is to determine CCTA-based atherosclerotic plaque characteristics that would help elucidate precursors of incident ACS, with the secondary objective being an analysis of gender-specific disparities.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Pericoronary Adipose Tissue Attenuation in Patients with Future Acute Coronary Syndromes: The ICONIC Study.
Kwan AC, Tzolos E, Klein E, Han D, et al · · 2025 · cited 2× · PMID 40539913 · DOI 10.1148/ryct.240200

Verify or expand the search:

Other recruiting trials for Atherosclerosis

Currently open trials in the same condition.

NCT07448038 — A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vas · Phase 2 · recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT06788431 — A Clinical Study of IMC-001 for Injection in Improving Atherosclerotic Plaque Stability in Patients With Acute Coronary · EARLY_PHASE1 · recruiting
NCT06676046 — Natural History of Uncommon Dyslipidemias, Rare Lipid Disorders and Unusual Atherosclerotic Conditions · recruiting
NCT06694012 — Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2 · recruiting

Other Weill Medical College of Cornell University trials

Trials by the same sponsor.

NCT07485712 — Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 2 · NA · not yet recruiting
NCT05811338 — Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 1 · NA · not yet recruiting
NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
NCT06818734 — Implementation of a Clinical Decision Support Tool for Postpartum Depression · NA · not yet recruiting
NCT07485725 — Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 3 · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02959099 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Weill Medical College of Cornell University
Last refreshed: 19 November 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02959099.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing